Latest On Sensus Healthcare, Inc (SRTS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-17 22:07 EST | News | Sensus Healthcare's SRT-100 system shows promising results in treating mast cell tumors in pets, study finds | N/A |  |
| 2023-05-04 16:51 EST | News | Sensus slumps ~40% after Q1 revenue falls on lower demand for SRT systems | N/A | |
| 2023-05-04 04:10 EST | News | Sensus Healthcare GAAP EPS of -$0.12 misses by $0.25, revenue of $3.4M misses by $6.73M | N/A | |
| 2023-05-04 04:10 EST | News | Sensus Healthcare, Inc. (SRTS) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-03 02:49 EST | News | Sensus Healthcare Q1 2023 Earnings Preview | N/A | |
About Sensus Healthcare, Inc (SRTS):
Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary modulated robotic brachytherapy oncology therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel read more...service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
General
- Name Sensus Healthcare, Inc
- Symbol SRTS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 42
- Fiscal Year EndDecember
- IPO Date2016-06-03
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://www.sensushealthcare.com
Valuation
- Forward PE 416.67
- Price/Sales (Trailing 12 Mt.) 7.48
- Price/Book (Most Recent Quarter) 3.31
- Enterprise Value Revenue 6.02
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.13
- Next Year EPS Estimate $0.06
- Next Quarter EPS Estimate -$0.11
- Profit Margin -71%
- Operating Margin -86%
- Return on Assets -16%
- Return on Equity -28%
- Revenue 9.58 million
- Earnings Per Share -$0.15
- Revenue Per Share $0.58
- Gross Profit 5.25 million
- Quarterly Earnings Growth -40.1%
Highlights
- Market Capitalization 72.54 million
- EBITDA -2277744
- PE Ratio 16.08
- Analyst Target Price $6.71
- Book Value Per Share $1.30
Share Statistics
- Shares Outstanding 16.49 million
- Shares Float 11.38 million
- % Held by Insiders 3111%
- % Held by Institutions 7.75%
- Shares Short 202833
- Shares Short Prior Month 195684
- Short Ratio 0.18
- Short % of Float 2%
- Short % of Shares Outstanding 1%
Technicals
- Beta 0.52
- 52 Week High $5.01
- 52 Week Low $1.76
- 50 Day Moving Average 4.17
- 200 Day Moving Average 3.37
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Sensus Healthcare, Inc (SRTS) Dividend Calendar:
Sensus Healthcare, Inc (SRTS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Sensus Healthcare, Inc (SRTS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Sensus Healthcare, Inc (SRTS) Chart:
Sensus Healthcare, Inc (SRTS) News:
Below you will find a list of latest news for Sensus Healthcare, Inc (SRTS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Sensus Healthcare, Inc (SRTS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest SRTS Trades:
Sensus Healthcare, Inc (SRTS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-05 | 8-K (Current report) | |
| 2020-11-05 | 8-K (Current report) | |
| 2020-10-02 | 10-K/A (Annual report [Section 13 and 15(d), not S-K Item 405]) | |
| 2020-08-10 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-08-06 | 8-K (Current report) | |
| 2020-08-04 | 8-K (Current report) | |
| 2020-06-10 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-06-10 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-06-10 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-06-05 | 8-K (Current report) | |
| 2020-06-04 | 25-NSE (Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret) | |
| 2020-06-01 | 8-K (Current report) | |
| 2020-05-29 | SD () | |
| 2020-05-11 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-05-07 | 8-K (Current report) | |
| 2020-05-05 | DEFR14A (Revised definitive proxy soliciting materials) | |
| 2020-04-29 | DEF 14A (Other definitive proxy statements) | |
| 2020-03-06 | 10-K (Annual report [Section 13 and 15(d), not S-K Item 405]) | |
| 2020-02-13 | 8-K (Current report) | |
| 2020-01-17 | 3 (Initial statement of beneficial ownership of securities) | |
Sensus Healthcare, Inc (SRTS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sensus Healthcare, Inc (SRTS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3111%
Institutional Ownership: 775%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-03-22 | Richard Golin | EXECUTIVE VICE PRESIDENT | Sell | 492.00 | 7.50 | 3,690.00 | 924,236.00 | |
| 2019-03-22 | Stephen Brad Cohen | EXECUTIVE VICE PRESIDENT | Sell | 595.00 | 7.50 | 4,462.50 | 930,585.00 | |
| 2019-03-22 | Kalman Fishman | CHIEF TECHNOLOGY OFFICER | Sell | 173.00 | 7.50 | 1,297.50 | 931,007.00 | |
| 2019-03-21 | Richard Golin | EXECUTIVE VICE PRESIDENT | Sell | 509.00 | 7.50 | 3,817.50 | 924,728.00 | |
| 2019-03-20 | Richard Golin | EXECUTIVE VICE PRESIDENT | Sell | 5,943.00 | 7.56 | 44,929.08 | 925,237.00 | |
| 2018-09-11 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Sell | 1,052.00 | 7.51 | 7,900.52 | 1,538,649.00 | |
| 2018-09-11 | Arthur Levine | CHIEF FINANCIAL OFFICER | Sell | 60.00 | 7.51 | 450.60 | 201,337.00 | |
| 2018-09-11 | Kalman Fishman | CHIEF TECHNOLOGY OFFICER | Sell | 631.00 | 7.51 | 4,738.81 | 931,180.00 | |
| 2018-09-11 | Richard Golin | EXECUTIVE VICE PRESIDENT | Sell | 631.00 | 7.51 | 4,738.81 | 931,180.00 | |
| 2018-09-11 | Stephen Brad Cohen | EXECUTIVE VICE PRESIDENT | Sell | 631.00 | 7.51 | 4,738.81 | 931,180.00 | |
| 2018-09-10 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Sell | 1,857.00 | 7.55 | 14,020.35 | 1,539,701.00 | |
| 2018-09-10 | Arthur Levine | CHIEF FINANCIAL OFFICER | Sell | 106.00 | 7.55 | 800.30 | 201,397.00 | |
| 2018-09-10 | Kalman Fishman | CHIEF TECHNOLOGY OFFICER | Sell | 1,114.00 | 7.55 | 8,410.70 | 931,811.00 | |
| 2018-09-10 | Richard Golin | EXECUTIVE VICE PRESIDENT | Sell | 1,114.00 | 7.55 | 8,410.70 | 931,811.00 | |
| 2018-09-10 | Stephen Brad Cohen | EXECUTIVE VICE PRESIDENT | Sell | 1,114.00 | 7.55 | 8,410.70 | 931,811.00 | |
| 2018-08-29 | Joseph C Sardano | CHIEF EXECUTIVE OFFICER | Sell | 322.00 | 7.50 | 2,415.00 | 1,541,558.00 | |
| 2018-08-29 | Arthur Levine | CHIEF FINANCIAL OFFICER | Sell | 19.00 | 7.50 | 142.50 | 201,503.00 | |
| 2018-08-29 | Kalman Fishman | CHIEF TECHNOLOGY OFFICER | Sell | 193.00 | 7.50 | 1,447.50 | 932,925.00 | |
| 2018-08-29 | Richard Golin | EXECUTIVE VICE PRESIDENT | Sell | 193.00 | 7.50 | 1,447.50 | 932,925.00 | |
| 2018-08-29 | Stephen Brad Cohen | EXECUTIVE VICE PRESIDENT | Sell | 193.00 | 7.50 | 1,447.50 | 932,925.00 | |